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Leukemia represents a diverse group of malignant diseases with a hematopoietic 
disorder with different prognoses. As the incidence of patients with leukemia is 
increasing, is an effort to establish the treatment that will lead to successful therapy. 
One of the basic approaches to the treatment of leukemias is chemotherapy. Today it is 
known that the effectiveness of chemotherapy is influenced by a number of factors 
which can significantly affect the treatment strategy and thus decide on the outcome of 
the treatment itself. An important approach in chemotherapy is the selection of 
cytostatics with maximum efficacy for oncological disease and elimination cytostatics 
to which the cells are resistant based on the findings in in vitro conditions. 
The aim of this diploma thesis was to determine the inhibitory effects of in vitro 
selected chemotherapeutics in cell tumor lines. For determine the inhibitory effect, 
HCT116, HepG2 and HL-60 cell lines were selected using a colorimetric method based 
on the determination of amount metabolically active cells (MTT and XTT assay). The 
subjects of the study were antimetabolites (cladribine, cytarabine), alkylation cytostatics 
(cyclophosphamide), anthracyclines (daunorubicin), prednisolone and all-trans-retinoic 
acid. 
Based on in vitro results, we could determine the lowest possible concentration of 
selected cytostatics with sufficient inhibitory activity. From these findings, we further 
concluded that inhibitory effects of cytotoxic agents would be appropriate in 
combination studies. The combination of cytostatics may favorably affect the 
therapeutic effect at lower concentrations than cytotoxic drugs themselves, and so we 
may reduce side effects. 
 
